The Centers for Disease Control and Prevention holds patents on the use of Truvada for HIV prevention, according to advocates, who want Gilead Sciences to pay future and retroactive royalties to make ...
The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis (PrEP), but will that ensure the ...
According to CDC statistics, only 25% of the approximately 1.2 million Americans who could benefit from PrEP had prescriptions in 2020. As the Bay Area Reporter has previously reported, people of ...
The Centers for Disease Control and Prevention estimates almost one-third of healthcare providers are unaware of pre-exposure prophylaxis’ benefits, according to Vaccine News. 1. When PrEP is taken as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback